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Abstract
Background: More optimistic perceptions of cardiovascular disease risk are associated with substantively lower
rates of cardiovascular death among men. It remains unknown whether this association represents causality (i.e.
perception leads to actions/conditions that influence cardiovascular disease occurrence) or residual confounding by
unmeasured factors that associate with risk perceptions and with physiological processes that promote
cardiovascular disease (i.e. inflammation or endothelial dysfunction).
Purpose: To evaluate whether previously unmeasured biological markers of inflammation or endothelial
dysregulation confound the observed association between cardiovascular disease risk perceptions and
cardiovascular disease outcomes;
Methods: We conducted a nested case-cohort study among community-dwelling men from Southeastern New
England (USA) who were interviewed between 1989 and 1990 as part of the Pawtucket Heart Health Program. We
measured C-reactive protein (CRP) and Vascular Endothelial Growth Factor (VEGF) levels from stored sera for a
random sample of the parent cohort (control sample, n = 127) and all cases of cardiovascular death observed
through 2005 (case sample, n = 44). We evaluated potential confounding using stratified analyses and logistic
regression modeling.
Results: Optimistic ratings of risk associated with lower odds of dying from cardiovascular causes among men
(OR = 0.39, 95% CI = 0.17, 0.91). Neither CRP nor VEGF confounded these findings.
Conclusions: The strong cardio-protective association between optimistic ratings of cardiovascular disease risk and
lower rates of cardiovascular mortality among men is not confounded by baseline biomarkers of systemic
inflammation or endothelial dysfunction.
Background
Optimistic perceptions of cardiovascular disease (CVD)
risk are common [1-7] and often targeted by public
health risk communication campaigns in hopes of chan-
ging CVD risk behavior (i.e. raising perception of CVD
risk to motivate heart healthy actions) [7]. However, a
growing body of work observes that optimistic percep-
tions of CVD risk predict lower rates of myocardial
infarction [8-10], thus raising the question of whether
seeking to overcome these “optimistic biases” will bene-
fit or harm public health.
Considering plausible causal mechanisms via which
optimistic biases might act to prevent heart disease is
important; however, we must also thoroughly examine
whether our prior observations of the CVD risk percep-
tion–outcome association are, in fact, confounded by
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unmeasured CVD risk factors. Risk perceptions are
plausibly influenced by psychological conditions (i.e.
personality, mood, coping style) that influence inflam-
matory status and endothelial reactivity. Since biomar-
kers of systemic inflammation (C-reactive protein) and
endothelial dysregulation (Vascular Endothelial Growth
Factor) also predict CVD events [11-16], these physiolo-
gic processes represent important pathways for potential
confounding of the risk perception–CVD outcome asso-
ciation (see conceptual diagram in Figure 1). We
hypothesize that controlling for markers of systemic
inflammation and endothelial dysregulation will weaken
earlier observations of a strong protective association
between optimistic ratings of CVD risk and 15-year
CVD mortality among community-dwelling men [9].
Methods
Overview
We conducted a case-cohort study nested within a com-
munity-based sample of men from southeastern New
England (USA). A case-cohort study is an efficient epi-
demiologic design similar to a case-control study, except
that the control group is chosen without regard to the
outcome (i.e. a random sample of the base population),
thus allowing comparison to multiple “case” groups (e.g.
cardiovascular death, as in the current analysis). This
strategy averts the time and financial cost of analyzing
frozen sera from a full cohort.
All participants completed household interviews
between 1990 and 1993. Serum samples were obtained
during household interviews and frozen per standard
protocol. Death record information was obtained from
the National Death Index through December 2005 to
identify cases. In depth description of this nested case-
cohort study [16] and the parent cohort [9] from which
participants were sampled has been published
elsewhere.
Participants and eligibility
All participants were enrolled during the post-interven-
tion period of the Pawtucket Heart Health Program
(PHHP), a controlled community intervention designed
to lower prevalence of CVD risk factors [17]. One thou-
sand one hundred seventy four men from the interven-
tion and control cities who were between the ages of 40
and 74 years and had no personal history of myocardial
infarction completed household interviews in the years
immediately following the PHHP intervention (1989-
1991). From this base population, sera were analyzed for
all 44 cases of cardiovascular death identified through
2005 (see description below) and for a random sub-
cohort of 127 men that was selected without regard to
outcome. The random sub-cohort included 9 of the 44
cases.
Exposure definition
Participants were asked at the beginning of the house-
hold interview, “Compared with persons of your own
age and sex, how would you rate your risk of having a
heart attack or stroke within the next 5 years?” Partici-
pants rated their CVD risk as “high”, “average”, “low”, or
“don’t know”. Endorsing one’s risk to be lower than
average we refer to as an optimistic rating.
Case definition and selection
We obtained the date of death and underlying cause of
death by linking personal identifiers (first name, middle
initial, last name, sex, exact day/month/year of birth) for
each participant to the Center for Disease Control
National Death Index (NDI) for the years 1990-2005.
Linkage and cause of death were established using NDI-
standardized protocols. Cases were those participants
whose primary or contributing cause of death was due
to cardiovascular disease, as defined by International
Classification of Disease (ICD) codes for coronary heart
disease or stroke (ICD-9 codes: 410-414 and 430-438;
ICD 10 codes: 120-125 and 160-169).
Biomarker measurement
Using thawed sera, the concentrations of CRP and
VEGF were measured using immunoturbidimetric and
ELISA assays, respectively. Prior epidemiologic research
has verified the validity of these samples and measure-
ment procedures [16].
Figure 1 Hypothetical sources of unmeasured confounding
and adjustment for CRP and VEGF. E = Comparative optimism in
heart disease risk. O = CVD death. C = Systemic inflammation/
endothelial dysfunction. U = Unmeasured potential confounder (e.g.
personality, mood) A Directed Acyclic Graph (DAG) is a useful
methodological tool for considering bias and confounding in
complex associations. The DAG shown above in Figure 1 graphically
represents how measures of systemic inflammation and endothelial
dysfunction, C, relate to a set of plausible, yet unmeasured
psychological confounders, U (i.e. mood, self-rated health, and
personality) of the relation between comparatively optimistic ratings
of CVD risk, E, and CVD death, O. Under hypothetical conditions
where unmeasured psychological factors contributed to substantial
residual confounding, adjusting for C (as this study does) blocks
major physiological pathways that would be responsible for such
residual confounding by U.
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Confounding and Effect Measure Modification
We considered the following as potential confounders or
effect measure modifiers of the association between
comparably optimistic self-rated CVD risk and CVD
mortality: CRP, VEGF, age, race/ethnicity, income, edu-
cation, foreign birth, city, Framingham Risk Score, total/
HDL cholesterol ratio, hypertension, smoking status,
body mass index, 1st degree family history of early-onset
coronary heart disease, current use of lipid or blood
pressure lowering medications, current aspirin use, phy-
sical inactivity, alcohol, and psychotropic medications.
Analyses
We evaluated the frequency and distribution of key
study variables. For univariate comparisons shown in
Table 1, we used the chi-square (categorical variables)
and the Student’s t-test (continuous variables) for deter-
mining statistical significance. Both VEGF and CRP
demonstrated substantially skewed distributions with
long right-sided tails. Thus, for all analyses considering
these biomarkers as continuous variables, we perform
natural logarithm transformations. Next, we evaluated
potential confounder status for both CRP and VEGF by
examining their association with optimistic ratings of
risk in the random sub-cohort, since this represents the
source population from which cases arise. Similarly, we
examined whether CRP and VEGF were associated with
CVD mortality, using the full case-cohort sample. We
performed similar analyses for other potential confound-
ing variables.
Since more elaborate adjustment for potential social,
biologic and behavioral confounders (propensity score
analysis [18] and censoring of early follow-up time) did
not improve upon age and Framingham Heart Score
adjustment in the parent cohort [9], we limited adjust-
ment methods here to multivariate logistic regression
modeling.
We used SAS software (Cary, NC) for all statistical
analyses. Where p-values are reported, we used a statis-
tical significance threshold of 0.05.
The institutional research review boards at Memorial
Hospital of Rhode Island and the University of Roche-
ster School of Medicine and Dentistry approved this
study.
Results
Thirty one percent of the participants endorsed their
risk of having a cardiovascular event in the next five
years as lower than average for their age and sex (i.e.
optimistic ratings). Forty-four participants died of cardi-
ovascular causes during the 15-year surveillance period.
Higher levels of CRP and VEGF were associated with
higher risk of CVD mortality (see Table 1). Differences
in log-transformed mean levels of VEGF (5.51 versus
5.38; p = 0.37) and CRP (0.56 versus 0.52; p = 0.83) for
comparative optimists compared to others were small
and statistically insignificant.
The association between comparative optimism and a
lower probability of CVD death was strong (OR = 0.39,
95% CI = 0.17, 0.91). Adjusting for CRP alone, VEGF
alone, or in combination with age, income and Framing-
ham Risk Score did not substantially change these find-
ings [see Table 2]. Similar results were observed for
biomarker classification as a continuous (log-trans-
formed) or categorical (tertile) variable.
Discussion and Conclusions
Following previous findings of an independent associa-
tion between optimistic perceptions of CVD risk and
substantially lower rates of CVD mortality among men,
we evaluated whether biomarkers of stress (i.e. inflam-
mation and endothelial dysregulation) would confound
these provocative observations. We observed that con-
trolling for baseline CRP and VEGF did not weaken the
protective association between optimistic ratings of
CVD risk and CVD mortality.
Psychosocial and behavioral processes related to self-
enhancement and optimism might explain our findings.
Believing that one is invulnerable from future problems
may enhance motivation to pursue other activities that,
in turn, buffer the effect of stress on CVD risk. In addi-
tion, people who perceive lower risk may also plan to
take measures to reduce risk, making their perceptions
accurate.
Another possible explanation is that optimistic rat-
ings of CVD risk reflect an optimistic personality.
Optimists seem to experience better health than non-
optimists. Among cardiac patients, optimists show fas-
ter recovery from cardiac bypass surgery [19] and are
less likely to be hospitalized 6 months post-surgery
[20]. The beneficial health effects of optimism may
arise from the different ways that optimists and pessi-
mists cope with stress. Optimism is correlated with
active and problem-focused coping strategies [21] that
may lead to better health practices. Research has found
that optimists do seem to be more effective in chan-
ging their own health behaviors and they report enga-
ging in more healthy behaviors than do pessimists
[22]. For example, when compared with pessimistic
patients, optimistic cardiac patients were more suc-
cessful in lowering their fat intake and getting more
exercise [23]. However, prior work observes that the
correlation between optimistic risk perceptions and
global optimism is weak, ranging from r = 0.14 to r =
0.33 [24], thus suggesting that optimistic appraisal of
one’s CVD risk represents a sub-domain of optimism
with potentially important cardio-protective
implications.
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Table 1 Description of Sample by Case Status
No CVD death (n = 118) CVD death (n = 44)
Comparative optimists (%)* 36.4 18.2
City (%)
Pawtucket 40.7 40.9
Control City 59.3 59.1
Race (%)
African-American 10.2 4.6
Asian/Pac Island 1.7 4.6
Native American 0.0 2.3
White 88.1 88.6
Hispanic Ethnicity (%) 1.7 4.6
Age (%)*
<45 21.2 6.8
45-64 61.9 52.3
65+ 16.9 40.9
Education (%)
<HS 49.2 45.5
HS 22.9 29.6
Some Coll 11.9 15.9
Coll Grad+ 16.1 9.1
Income (%)
<$10,000 10.9 17.5
$10,000-$19,999 27.3 42.5
$20,000-$29,999 22.7 20.0
$30,000-$39,999 10.9 7.5
$40,000-$49,999 8.2 2.5
$50,000+ 20.0 10.0
Foreign Born (%) 36.4 27.3
Current Cigarette Smoker (%) 28.0 36.4
Physical Inactivity (%) 64.4 61.4
BMI - mean (SD) 27.7 (4.08) 28.0 (4.94)
Self-reported DM (%)* 5.9 22.7
Hypertension (%)* 50.0 77.3
TC - mean (SD) 227 (43.2) 228 (38.7)
HDL - mean (SD)** 45 (12.1) 41 (10.8)
C-reactive protein
Mean (SD)**¶ 0.45 (1.12) 1.36 (1.14)
Tertiles (%)*‡
1 34.8 9.1
2 33.9 38.6
3 31.4 52.3
Vascular Endothelial Growth Factor
Mean (SD)**¶ 5.42 (0.74) 5.70 (0.57)
Tertiles (%)*‡
1 34.2 11.6
2 33.3 30.2
3 32.5 58.1
*p < 0.05 on chi-square test; **p < 0.05 on Student’s t-test; ¶ log transformed
‡ Tertiles defined by biomarker distribution among sub-cohort chosen without respect for outcome status [CRP: < 0.96 = T1, 0.96-2.82 = T2, >2.82 = T3;
VEGF: <166 = T1, 166-299 = T2, >299 = T3]
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Fiscella [25] raises important questions about whether
optimistic ratings of health status–well known to predict
survival [26]– confound the cardio-protective associa-
tion with optimistic self-ratings of CVD risk observed in
this cohort. Health status was not measured, thus pre-
cluding us from directly addressing confounding (or
interaction between optimistic ratings of health status
and risk). However, optimistic self-rated health is asso-
ciated with lower levels of systemic inflammation
[27,28]. We observed no such relationship between opti-
mistic ratings of CVD risk and systemic inflammation.
Furthermore, controlling for systemic inflammation
failed to weaken the observed cardio-protective effects
of optimistic ratings of CVD risk. Thus, we conclude
that unmeasured confounding by self-rated health status
is unlikely to threaten the validity of the strong relation-
ship observed in the present study.
Our findings do not rule out the possibility for sys-
temic inflammation or endothelial dysregulation to
represent a partial causal mechanism linking risk per-
ceptions to CVD mortality. For example, if heightened
awareness of CVD risk leads to fear-related behaviors
and physiological responses that promote systemic
inflammation or endothelial reactivity, downstream
effects on CRP levels might be observed. We measured
CRP and VEGF at baseline only. Although this provides
strong evidence that these biomarker-related phenom-
ena do not confound the association between compara-
tive optimism and CVD mortality, longitudinal
assessment is necessary to determine the degree to
which changes in systemic inflammation or endothelial
dysregulation represents a causal pathway linking CVD
risk perceptions and CVD death.
A better understanding of the substantial cardio-pro-
tective association between optimistic risk perceptions
and cardiovascular health is essential to guide the pre-
ventive applications for emerging technologies (e.g.
advanced imaging, predictive genomics) that will shape
our society’s understanding of cardiovascular risk.
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